CMPX - Compass Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$11.20
DETAILS
HIGH:
$15.00
LOW:
$9.00
MEDIAN:
$10.00
CONSENSUS:
$11.20
UPSIDE:
441.06%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Revenue | 0 | 0.8 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 1.5 | 0 | 0 | 0 | 0 | 0 | 0 | 1.9 |
| Gross Profit | (1.5) | 0.8 | 0 | 0 | 0 | 0 | 0 | (1.9) |
| Operating Expenses | ||||||||
| R&D Expenses | 56.0 | 42.3 | 38.1 | 30.0 | 20.3 | 14.9 | 22.4 | 27.1 |
| SG&A Expenses | 16.9 | 15.1 | 12.2 | 11.7 | 10.9 | 12.9 | 11.6 | 11.2 |
| Other Expenses | (1.5) | 0 | 0 | 0 | 50.6 | 0 | 0 | 0 |
| Operating Expenses | 71.4 | 57.5 | 50.4 | 41.7 | 81.9 | 27.8 | 34.1 | 38.3 |
| Operating Income | ||||||||
| Operating Income | (72.8) | (56.6) | (50.4) | (41.7) | (81.9) | (27.8) | (34.1) | (38.3) |
| Interest Expense | 0 | 0 | 0 | 2.4 | 0.4 | 0.9 | 1.2 | 0.8 |
| Interest Income | 6.3 | 7.3 | 0 | 2.4 | 0.0 | 0.1 | 0.7 | 0.7 |
| Profitability | ||||||||
| EBITDA | (71.4) | (54.9) | (48.5) | (39.8) | (80.2) | (25.4) | (31.9) | (35.7) |
| EBIT | (72.8) | (56.6) | (50.4) | (41.7) | (81.8) | (27.8) | (34.1) | 0 |
| Income Before Tax | (66.5) | (49.4) | (42.5) | (39.2) | (82.2) | (29.5) | (34.7) | (38.2) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0.0 | 0.1 | 0.1 |
| Net Income | (66.5) | (49.4) | (42.5) | (39.2) | (82.2) | (29.5) | (34.7) | (38.3) |
| Per Share Data | ||||||||
| EPS (Basic) | -0.42 | -0.36 | -0.33 | -0.35 | -1.31 | -0.52 | -0.67 | -7.66 |
| EPS (Diluted) | -0.42 | -0.36 | -0.33 | -0.35 | -1.31 | -0.52 | -0.67 | -7.66 |
| Shares Outstanding | 157.7 | 137.1 | 127.0 | 105.2 | 62.9 | 56.2 | 52.1 | 5 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||
| Cash & Cash Equivalents | 30.6 | 43.5 | 24.2 | 34.9 | 144.5 | 47.1 | 25.3 | 57.5 |
| Short-Term Investments | 178.3 | 83.2 | 128.2 | 151.7 | 0 | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0.9 | 6.0 | 1.4 | 8.2 | 0 | 0 | 0 | 1.4 |
| Total Current Assets | 209.8 | 132.8 | 153.9 | 194.8 | 147.1 | 50.2 | 26.2 | 58.9 |
| Non-Current Assets | ||||||||
| Property, Plant & Equipment | 9.2 | 7.1 | 2.7 | 4.5 | 6.3 | 1.1 | 3.8 | 5.4 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.3 |
| Other Non-Current Assets | 0.6 | 0.6 | 0.3 | 0.3 | 0.3 | 0.6 | 0.4 | 0.1 |
| Total Non-Current Assets | 9.8 | 7.7 | 3.0 | 4.9 | 6.7 | 1.7 | 4.1 | 5.7 |
| Total Assets | 219.6 | 140.4 | 156.9 | 199.6 | 153.8 | 51.9 | 30.4 | 64.6 |
| Current Liabilities | ||||||||
| Account Payables | 1.6 | 2.2 | 4.1 | 3.4 | 0.9 | 1.1 | 0.6 | 1.7 |
| Short-Term Debt | 1 | 0 | 0 | 0 | 0 | 7.5 | 5.6 | 3.7 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.5 |
| Other Current Liabilities | 11.4 | 2.8 | 1.9 | 1.6 | 1.6 | 1.0 | 2.3 | 2.5 |
| Total Current Liabilities | 14.0 | 8.9 | 7.8 | 16.2 | 10.6 | 10.1 | 9.8 | 8.5 |
| Non-Current Liabilities | ||||||||
| Long-Term Debt | 8.8 | 0 | 0 | 0 | 0 | 1.9 | 9.3 | 11.1 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0.0 | 0 | 0 | 0 | 0 | 129.9 | 129.9 |
| Total Non-Current Liabilities | 8.8 | 6.3 | 0.5 | 1.8 | 3.0 | 1.9 | 139.2 | 140.9 |
| Total Liabilities | 22.8 | 15.2 | 8.3 | 18.0 | 13.7 | 12.0 | 149.0 | 149.4 |
| Stockholders' Equity | ||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.4 |
| Retained Earnings | (431.2) | (364.7) | (315.3) | (272.8) | (233.6) | (151.4) | (121.9) | (87.2) |
| Accumulated Other Comprehensive Income | 0.3 | 0.2 | 0.0 | (0.3) | 0 | 0 | 0 | (4.1) |
| Total Stockholders' Equity | 196.8 | 125.2 | 148.5 | 181.6 | 140.1 | 39.9 | (118.6) | (84.8) |
| Total Liabilities & Equity | 219.6 | 140.4 | 156.9 | 199.6 | 153.8 | 51.9 | 30.4 | 64.6 |
| Debt Metrics | ||||||||
| Total Debt | 9.8 | 6.6 | 1.7 | 2.9 | 4.0 | 9.3 | 14.9 | 14.8 |
| Net Debt | (20.8) | (36.8) | (22.5) | (32.0) | (140.5) | (37.7) | (10.4) | (42.8) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | (66.5) | (49.4) | (42.5) | (39.2) | (82.2) | (29.5) | (34.7) | (38.3) |
| Depreciation & Amortization | (1.4) | 1.8 | 1.9 | 1.9 | 1.6 | 2.4 | 2.1 | 1.9 |
| Stock-Based Compensation | 8.4 | 8.6 | 6.1 | 5.3 | 4.0 | 4.0 | 0.9 | 0.7 |
| Change in Working Capital | 9.2 | (4.1) | (2.9) | (1.3) | 6.2 | (3.6) | (0.3) | 2.2 |
| Other Non-Cash Items | 1.2 | (1.7) | 6.0 | (0.9) | 0.0 | (1.0) | 0.1 | 0.1 |
| Operating Cash Flow | (49.1) | (44.9) | (40.6) | (34.1) | (19.7) | (26.8) | (31.7) | (33.7) |
| Investing Activities | ||||||||
| Capital Expenditure | (0.0) | (0.0) | (0.0) | (0.2) | (1.6) | (0.1) | (0.5) | (2.0) |
| Acquisitions | 0 | 0 | 0 | 0.2 | 0.1 | 0.1 | 0 | 0 |
| Purchases of Investments | (194.6) | (88.2) | (155.4) | (200.1) | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 101.3 | 135.0 | 182.4 | 49.0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0.0 | (0.2) | (0.3) | 0.0 | 0 | 0 |
| Investing Cash Flow | (93.3) | 46.8 | 27.0 | (151.2) | (1.8) | 0.0 | (0.5) | (2.0) |
| Financing Activities | ||||||||
| Net Debt Issuance | 0 | 0 | – | – | – | – | – | – |
| Stock Repurchased | 0 | 0 | (0.0) | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.0) | (0.8) | (0.2) | (0.5) | (0.3) | (6.3) | 0.0 | 64.0 |
| Financing Cash Flow | 129.6 | 17.3 | 2.9 | 75.8 | 118.6 | 48.5 | 0.0 | 64.0 |
| Cash Position | ||||||||
| Net Change in Cash | (12.8) | 19.3 | (10.7) | (109.6) | 97.2 | 21.8 | (32.2) | 28.3 |
| Cash at Beginning | 44.1 | 24.2 | 34.9 | 144.5 | 47.3 | 25.6 | 57.8 | 29.4 |
| Cash at End | 31.2 | 43.5 | 24.2 | 34.9 | 144.5 | 47.3 | 25.6 | 57.8 |
| Free Cash Flow | (49.2) | (44.9) | (40.6) | (34.3) | (21.2) | (26.9) | (32.2) | (35.7) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0 | 0.8 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | (1.5) | 0.8 | 0 | 0 | 0 | 0 | 0 | (1.9) |
| Operating Income | (72.8) | (56.6) | (50.4) | (41.7) | (81.9) | (27.8) | (34.1) | (38.3) |
| Net Income | (66.5) | (49.4) | (42.5) | (39.2) | (82.2) | (29.5) | (34.7) | (38.3) |
| EPS (Diluted) | -0.42 | -0.36 | -0.33 | -0.35 | -1.31 | -0.52 | -0.67 | -7.66 |
| Balance Sheet | ||||||||
| Cash & Equivalents | 30.6 | 43.5 | 24.2 | 34.9 | 144.5 | 47.1 | 25.3 | 57.5 |
| Total Assets | 219.6 | 140.4 | 156.9 | 199.6 | 153.8 | 51.9 | 30.4 | 64.6 |
| Total Debt | 9.8 | 6.6 | 1.7 | 2.9 | 4.0 | 9.3 | 14.9 | 14.8 |
| Stockholders' Equity | 196.8 | 125.2 | 148.5 | 181.6 | 140.1 | 39.9 | (118.6) | (84.8) |
| Cash Flow | ||||||||
| Operating Cash Flow | (49.1) | (44.9) | (40.6) | (34.1) | (19.7) | (26.8) | (31.7) | (33.7) |
| Capital Expenditure | (0.0) | (0.0) | (0.0) | (0.2) | (1.6) | (0.1) | (0.5) | (2.0) |
| Free Cash Flow | (49.2) | (44.9) | (40.6) | (34.3) | (21.2) | (26.9) | (32.2) | (35.7) |